InfuSystem Holdings Inc
AMEX:INFU
Operating Margin
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
Peer Comparison
| Country | Company | Market Cap |
Operating Margin |
||
|---|---|---|---|---|---|
| US |
I
|
InfuSystem Holdings Inc
AMEX:INFU
|
157.3m USD |
Loading...
|
|
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD |
Loading...
|
|
| US |
|
Cigna Corp
NYSE:CI
|
75.3B USD |
Loading...
|
|
| US |
C
|
Cigna Group
XMUN:CGN
|
63.5B EUR |
Loading...
|
|
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
27.8B EUR |
Loading...
|
|
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.9B EUR |
Loading...
|
|
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
23.1B USD |
Loading...
|
|
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
21.3B USD |
Loading...
|
|
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.7B EUR |
Loading...
|
|
| US |
|
Guardant Health Inc
NASDAQ:GH
|
12.6B USD |
Loading...
|
|
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD |
Loading...
|
Market Distribution
| Min | -4 087 900% |
| 30th Percentile | -5.1% |
| Median | 6% |
| 70th Percentile | 14.8% |
| Max | 1 032 600% |
Other Profitability Ratios
InfuSystem Holdings Inc
Glance View
InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.
See Also
Operating Margin is calculated by dividing the Operating Income by the Revenue.
The current Operating Margin for InfuSystem Holdings Inc is 7.3%, which is above its 3-year median of 3.9%.
Over the last 3 years, InfuSystem Holdings Inc’s Operating Margin has increased from 0.9% to 7.3%. During this period, it reached a low of 0.9% on Jun 30, 2022 and a high of 7.3% on Jun 30, 2025.
